Literature DB >> 6184954

CSF monoamine metabolites in schizophrenic patients.

W F Gattaz, P Waldmeier, H Beckmann.   

Abstract

The monoamine metabolites 3-methoxy-4-hydroxyphenyglycol (MHPG), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were measured in the cerebrospinal fluid (CSF) of 16 psychiatrically health controls and in 28 schizophrenic patients. There was no difference in CSF MHPG and HVA levels between the group of patients and the controls. CSF levels of 5-HIAA were significantly lower in schizophrenic patients than in controls. Differential analysis of patients with and without neuroleptics revealed that these findings were not due to drug treatment. Positive correlations were found between the level of 5-HIAA and the items: hallucinatory behaviour, grandiosity, and tension as rated on the Brief Psychiatric Rating Scale. As 5-HIAA CSF data are controversial for nosological entities, the search for correlations between 5-HIAA and individual psychopathological variables could provide more specific indices for psychiatric diagnosis, treatment or prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184954     DOI: 10.1111/j.1600-0447.1982.tb06717.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  5 in total

1.  Clozapine pharmacology and tardive dyskinesia.

Authors:  J Lieberman; C Johns; T Cooper; S Pollack; J Kane
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.

Authors:  H Beckmann; P Waldmeier; J Lauber; W F Gattaz
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 3.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Marine Bacterial Compounds Evaluated by In Silico Studies as Antipsychotic Drugs Against Schizophrenia.

Authors:  Dhinesh Kumar Thiyagarajamoorthy; Charli Deepak Arulanandam; Hans-Uwe Dahms; Santhosh Gokul Murugaiah; Muthukumar Krishnan; Arthur James Rathinam
Journal:  Mar Biotechnol (NY)       Date:  2018-07-18       Impact factor: 3.619

Review 5.  Theranostic Biomarkers for Schizophrenia.

Authors:  Matea Nikolac Perkovic; Gordana Nedic Erjavec; Dubravka Svob Strac; Suzana Uzun; Oliver Kozumplik; Nela Pivac
Journal:  Int J Mol Sci       Date:  2017-03-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.